Onsdag 21 Maj | 08:06:43 Europe / Stockholm
Svenska | English

DNB Carnegie Access

Prenumeration

Initiator Pharma: Interview - Expanding into a new indication and announcing a capital raise
2025-05-19 15:30:00

The company presents its recently announced decision to expand the pipeline into vulvodynia within female sexual dysfunction, alongside details of its proposed capital raise. This is followed by a discussion with CEO Claus Elsborg Olesen.

Find the interview on DNB Carnegie Play: https://youtu.be/EuNCFK3FIHY
This is commissioned research from DNB Carnegie. Read more here: Carnegie Access - Carnegie

Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.

About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden